Search research articles
Contact Us
Filters
Showing results (171-180 of 349) with videos related to
Page
of 35
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 24, 2004
Haplotype structure and allele frequencies of CYP2B6 in a Korean population
Joo-Youn Cho, Hyeong-Seok Lim, Jae-Yong Chung, et al.
The AAPS Journal
|
May 20, 2017
Distribution of Exogenous and Endogenous CYP3A Markers and Related Factors in Healthy Males and Females
Jieon Lee, Andrew HyoungJin Kim, SoJeong Yi, et al.
Plos One
|
April 25, 2017
The novel carboxylesterase 1 variant c.662A>G may decrease the bioactivation of oseltamivir in humans
Jaeseong Oh, SeungHwan Lee, Howard Lee, et al.
Drug Design, Development and Therapy
|
May 9, 2017
A first-in-human, double-blind, placebo-controlled, randomized, dose escalation study of DWP05195, a novel TRPV1 antagonist, in healthy volunteers
Jieon Lee, Bo-Hyung Kim, Kyung-Sang Yu, et al.
Journal of Korean Medical Science
|
April 23, 2014
Seasonal variation in hemoglobin a1c in korean patients with type 2 diabetes mellitus
Yoon Ji Kim, Seongkeun Park, Wangjin Yi, et al.
Pharmaceuticals (Basel, Switzerland)
|
November 10, 2022
Safety, Tolerability, and Serum/Tear Pharmacokinetics of Human Recombinant Epidermal Growth Factor Eyedrops in Healthy Subjects
Hyounggyoon Yoo, Seonghae Yoon, In-Jin Jang, et al.
Drug Design, Development and Therapy
|
November 16, 2017
Comparable pharmacokinetics and pharmacodynamics of two epoetin alfa formulations Eporon<sup>®</sup> and Eprex<sup>®</sup> following a single subcutaneous administration in healthy male volunteers
Sumin Yoon, Su-Jin Rhee, Sun Ju Heo, et al.
Drug Design, Development and Therapy
|
February 14, 2015
A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects
Sang-In Park, Howard Lee, Jaeseong Oh, et al.
Clinical and Translational Science
|
April 25, 2023
Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl-tRNA synthetase inhibitor, in healthy subjects
Min Young Park, Sungyeun Bae, Jung A Heo, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
March 13, 2012
Assessment of pharmacokinetic proportionality of levofloxacin and cyclosporine over a 100-fold dose range in healthy human volunteers
Mi-sun Lim, Sook Jin Seong, Jeonghyeon Park, et al.
Page
of 35
Search research articles
Search
Showing results (171-180 of 349) with videos related to
Sort By:
Page
of 35
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 24, 2004
Haplotype structure and allele frequencies of CYP2B6 in a Korean population
Joo-Youn Cho, Hyeong-Seok Lim, Jae-Yong Chung, et al.
The AAPS Journal
|
May 20, 2017
Distribution of Exogenous and Endogenous CYP3A Markers and Related Factors in Healthy Males and Females
Jieon Lee, Andrew HyoungJin Kim, SoJeong Yi, et al.
Plos One
|
April 25, 2017
The novel carboxylesterase 1 variant c.662A>G may decrease the bioactivation of oseltamivir in humans
Jaeseong Oh, SeungHwan Lee, Howard Lee, et al.
Drug Design, Development and Therapy
|
May 9, 2017
A first-in-human, double-blind, placebo-controlled, randomized, dose escalation study of DWP05195, a novel TRPV1 antagonist, in healthy volunteers
Jieon Lee, Bo-Hyung Kim, Kyung-Sang Yu, et al.
Journal of Korean Medical Science
|
April 23, 2014
Seasonal variation in hemoglobin a1c in korean patients with type 2 diabetes mellitus
Yoon Ji Kim, Seongkeun Park, Wangjin Yi, et al.
Pharmaceuticals (Basel, Switzerland)
|
November 10, 2022
Safety, Tolerability, and Serum/Tear Pharmacokinetics of Human Recombinant Epidermal Growth Factor Eyedrops in Healthy Subjects
Hyounggyoon Yoo, Seonghae Yoon, In-Jin Jang, et al.
Drug Design, Development and Therapy
|
November 16, 2017
Comparable pharmacokinetics and pharmacodynamics of two epoetin alfa formulations Eporon<sup>®</sup> and Eprex<sup>®</sup> following a single subcutaneous administration in healthy male volunteers
Sumin Yoon, Su-Jin Rhee, Sun Ju Heo, et al.
Drug Design, Development and Therapy
|
February 14, 2015
A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects
Sang-In Park, Howard Lee, Jaeseong Oh, et al.
Clinical and Translational Science
|
April 25, 2023
Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl-tRNA synthetase inhibitor, in healthy subjects
Min Young Park, Sungyeun Bae, Jung A Heo, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
March 13, 2012
Assessment of pharmacokinetic proportionality of levofloxacin and cyclosporine over a 100-fold dose range in healthy human volunteers
Mi-sun Lim, Sook Jin Seong, Jeonghyeon Park, et al.
Page
of 35